Cargando…

ANGPTL4 gene E40K variation protects against obesity‐associated dyslipidemia in participants with obesity

OBJECTIVE: ANGPTL4 inhibits lipoprotein lipase in adipose tissue, regulating plasma triglycerides levels. In persons with obesity plasma ANGPTL4 levels have been positively correlated with body fat mass, TG levels and low HDL. A loss‐of‐function E40K mutation in ANGPTL4 prevents LPL inhibition, resu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bailetti, D., Bertoccini, L., Mancina, R. M., Barchetta, I., Capoccia, D., Cossu, E., Pujia, A., Lenzi, A., Leonetti, F., Cavallo, M. G., Romeo, S., Baroni, M. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381304/ https://www.ncbi.nlm.nih.gov/pubmed/30820332 http://dx.doi.org/10.1002/osp4.311

Ejemplares similares

The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight/obese children: a long-term follow-up study
por: Barchetta, I., et al.
Publicado: (2021)

Association of FTO Polymorphisms with Early Age of Obesity in Obese Italian Subjects
por: Sentinelli, Federica, et al.
Publicado: (2012)

Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity
por: Ceccarelli, Valentina, et al.
Publicado: (2020)

The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V
por: Bertoccini, Laura, et al.
Publicado: (2017)

Hypovitaminosis D is Independently Associated with Metabolic Syndrome in Obese Patients
por: Barchetta, Ilaria, et al.
Publicado: (2013)

Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity
por: Barchetta, Ilaria, et al.
Publicado: (2018)

Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Neurotensin Gene rs2234762 C>G Variant Associates with Reduced Circulating Pro-NT Levels and Predicts Lower Insulin Resistance in Overweight/Obese Children
por: Sentinelli, Federica, et al.
Publicado: (2023)

Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus
por: Cavallo, Maria Gisella, et al.
Publicado: (2012)

Deep Resequencing of 9 Candidate Genes Identifies a Role for ARAP1 and IGF2BP2 in Modulating Insulin Secretion Adjusted for Insulin Resistance in Obese Southern Europeans
por: Bailetti, Diego, et al.
Publicado: (2022)

Granzyme B Expression in Visceral Adipose Tissue Associates With Local Inflammation and Glyco-Metabolic Alterations in Obesity
por: Cimini, Flavia Agata, et al.
Publicado: (2020)

WISP1 Is a Marker of Systemic and Adipose Tissue Inflammation in Dysmetabolic Subjects With or Without Type 2 Diabetes
por: Barchetta, Ilaria, et al.
Publicado: (2017)

Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
por: Fukami, Hirotaka, et al.
Publicado: (2021)

Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity
por: Barchetta, Ilaria, et al.
Publicado: (2019)

Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia
por: Sosnowska, Bożena, et al.
Publicado: (2022)

Glycated hemoglobin for the diagnosis of diabetes and prediabetes: Diagnostic impact on obese and lean subjects, and phenotypic characterization
por: Incani, Michela, et al.
Publicado: (2015)

Variability in genes regulating vitamin D metabolism is associated with vitamin D levels in type 2 diabetes
por: Bertoccini, Laura, et al.
Publicado: (2018)

Effects of work status changes and perceived stress on glycaemic control in individuals with type 1 diabetes during COVID-19 lockdown in Italy
por: Barchetta, Ilaria, et al.
Publicado: (2020)

High pro-neurotensin levels in individuals with type 1 diabetes associate with the development of cardiovascular risk factors at follow-up
por: Cimini, Flavia Agata, et al.
Publicado: (2021)

Increased ANGPTL3, 4 and ANGPTL8/betatrophin expression levels in obesity and T2D
por: Abu-Farha, Mohamed, et al.
Publicado: (2016)

Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease
por: Cimini, Flavia A, et al.
Publicado: (2017)

ANGPTL-4 is Associated with Obesity and Lipid Profile in Children and Adolescents
por: Barja-Fernández, Silvia, et al.
Publicado: (2019)

Variable Changes of Circulating ANGPTL3 and ANGPTL4 in Different Obese Phenotypes: Relationship with Vasodilator Dysfunction
por: Schinzari, Francesca, et al.
Publicado: (2021)

Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans
por: Sentinelli, Federica, et al.
Publicado: (2011)

The COBLL1 C allele is associated with lower serum insulin levels and lower insulin resistance in overweight and obese children
por: Mancina, Rosellina Margherita, et al.
Publicado: (2013)

Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia
por: Chen, Pei-Yi, et al.
Publicado: (2021)

Associations of Betatrophin/ANGPTL8 with Septic Dyslipidemia in Human Peritonitis: An Explorative Analysis
por: Horn, Paul, et al.
Publicado: (2022)

Obesity and Dyslipidemia in South Asians
por: Misra, Anoop, et al.
Publicado: (2013)

Dyslipidemia and Obesity in Ischemic Stroke
por: Gajurel, Bikram P, et al.
Publicado: (2023)

New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3
por: Kim, Ji Yoon, et al.
Publicado: (2023)

Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity
por: Perdomo, Carolina M., et al.
Publicado: (2021)

Frequency of secondary dyslipidemia in obese children
por: Korsten-Reck, Ulrike, et al.
Publicado: (2008)

Dyslipidemia in Iranian overweight and obese children
por: Ghergerehchi, Robabeh
Publicado: (2009)

Dyslipidemia in Obesity: Mechanisms and Potential Targets
por: Klop, Boudewijn, et al.
Publicado: (2013)

The association of dyslipidemia and obesity with glycated hemoglobin
por: Sheth, Jayesh, et al.
Publicado: (2015)

Dyslipidemia, Obesity, and Ethnicity in Mexican Children
por: Costa-Urrutia, Paula, et al.
Publicado: (2021)

Circulating ANGPTL8/Betatrophin Is Increased in Obesity and Reduced after Exercise Training
por: Abu-Farha, Mohamed, et al.
Publicado: (2016)

Advances in Phenotyping Obesity and in Its Dietary and Pharmacological Treatment: A Narrative Review
por: Pujia, Roberta, et al.
Publicado: (2022)

Tackling Dyslipidemia in Obesity from a Nanotechnology Perspective
por: Trandafir, Laura M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b148en1ib5u3u7alnc2gag1fm6